SCHEMBL6581980

SCHEMBL6581980

Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Nc3ccccc3)n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 1.00
BRD4 O60885 6/20 0.79
BRDT Q58F21 2/20 0.79
BRD2 P25440 1/20 0.79
BRD3 Q15059 1/20 0.79
PRKD3 O94806 2/20 0.68
MAP4K4 O95819 2/20 0.68
PRKACA P17612 2/20 0.68
CSNK1A1 P48729 2/20 0.68
CSNK1D P48730 2/20 0.68
MINK1 Q8N4C8 2/20 0.68
MAP4K5 Q9Y4K4 2/20 0.68
MAPK13 O15264 1/20 0.68
RIPK2 O43353 1/20 0.68
DYRK3 O43781 1/20 0.68
PRKCG P05129 1/20 0.68
LCK P06239 1/20 0.68
LYN P07948 1/20 0.68
RET P07949 1/20 0.68
PIM1 P11309 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6794576 0.91 MAPK14 (0.85) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL22730369 0.91 MAPK14 (0.85) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6791353 0.90 MAPK14 (0.84) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6961445 0.90 MAPK14 (1.00) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6961441 0.90 MAPK14 (1.00) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6579510 0.89 MAPK14 (0.80) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6952550 0.89 MAPK14 (0.81) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6579077 0.88 MAPK14 (0.79) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL6577112 0.88 MAPK14 (0.79) MAPK14BRD4BRDTBRD2BRD3
SCHEMBL22730357 0.88 MAPK14 (1.00) MAPK14BRD4BRDTBRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1130358-C Imidazole compound and preparation method and application thereof SMITHKLINE BEECHAM CORP (US) 2003-12-10 CN claimed
EP-0831830-B1 IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-03-05 EP claimed
CN-1192147-A Imidazole compounds SMITHKLINE BEECHAM CORP (US) 1998-09-02 CN claimed
EP-0961618-B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen SMITHKLINE BEECHAM CORP (US) 2004-08-04 EP disclosed
CN-1130358-C Imidazole compound and preparation method and application thereof SMITHKLINE BEECHAM CORP (US) 2003-12-10 CN disclosed
CN-1382044-A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection SMITHKLINE BEECHAM CORP (US) 2002-11-27 CN disclosed
US-6369068-B1 Amino substituted pyrimidine containing compounds SMITHKLINE BEECHAM CORPORATION 2002-04-09 US disclosed
US-6255491-B1 CHEMICAL INTERMEDIATES SUCH AS 1-(SUBSTITUTED), 4-ARYL, 5-(3-N,N-DISUBSTITUTED AMINO-1-PROPENONE) IMIDAZOLE, USEFUL FOR MAKING 5-PYRIMIDINYL IMIDAZOLES SMITHKLINE BEECHAM CORPORATION 2001-07-03 US disclosed
US-6239279-B1 THERAPY FOR CYTOKINE SENSITIVE DISEASES SMITHKLINE BEECHAM CORPORATION 2001-05-29 US disclosed
US-6218537-B1 Process for making pyridyl and pyrimidine substituted imidazole compounds SMITHKLINE BEECHAM CORPORATION 2001-04-17 US disclosed
US-6100399-A Synthesis for 4-aryl-5-pyrimidine imidazole substituted compounds SMITHKLINE BEECHAM CORPORATION (US) 2000-08-08 US disclosed
US-5917043-A INTERMEDIATES SMITHKLINE BEECHAM CORPORATION (US) 1999-06-29 US disclosed
US-5869660-A Process of preparing imidazole compounds SMITHKLINE BEECHAM CORPORATION (US) 1999-02-09 US disclosed
CN-1192147-A Imidazole compounds SMITHKLINE BEECHAM CORP (US) 1998-09-02 CN disclosed
US-5739143-A Imidazole compounds and compositions SMITHKLINE BEECHAM CORPORATION (US) 1998-04-14 US disclosed
US-5658903-A Imidazole compounds, compositions and use SMITHKLINE BEECHAM CORPORATION (US) 1997-08-19 US disclosed